RPS6KA1 and small cell lung carcinoma: Based on these findings, we treated KRASG12V-inducible SCLC cells with an ERG inhibitor, ERGi-USU (Mohamed et al., 2018), with or without MSK/RSK inhibition (Figure 6—figure supplement 3a).